Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors:a randomised controlled trial

Transcend Investigators

Research output: Contribution to journalArticleScientificpeer-review

751 Citations (Scopus)
Original languageEnglish
Pages (from-to)1174-1181
JournalLancet
Volume372
Issue number9644
Publication statusPublished - 2008
Publication typeA1 Journal article-refereed

Cite this